Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Germ Cell Neoplasm”

1,672 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,672 results

Testing effectiveness (Phase 2)Study completedNCT01435369
What this trial is testing

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Medivation, Inc. 103
Early research (Phase 1)Ended earlyNCT00428272
What this trial is testing

HGS-ETR2 to Treat Children With Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaNeuroblastoma+1 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00281957
What this trial is testing

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 109
Not applicableEnded earlyNCT04895553
What this trial is testing

Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban

Who this might be right for
Glioma, Malignant
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00687765
What this trial is testing

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma
Sanofi 126
Not applicableLooking for participantsNCT03684109
What this trial is testing

Non-invasive Glioma Characterization Through Molecular Imaging

Who this might be right for
GliomaBrain TumorPrimary Brain Tumor+2 more
University of Miami 30
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Active Not RecruitingNCT05283109
What this trial is testing

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM

Who this might be right for
Glioma, Malignant
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 24
Large-scale testing (Phase 3)Study completedNCT01460706
What this trial is testing

Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT

Who this might be right for
Glioma
Turku University Hospital 30
Large-scale testing (Phase 3)Study completedNCT00782145
What this trial is testing

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Tufts Medical Center 198
Not applicableStudy completedNCT00339404
What this trial is testing

Genetic Analysis of Familial Melanoma

Who this might be right for
Melanoma
National Human Genome Research Institute (NHGRI) 3,000
Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Testing effectiveness (Phase 2)Study completedNCT00041587
What this trial is testing

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 80
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Looking for participantsNCT04323046
What this trial is testing

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+3 more
Sabine Mueller, MD, PhD 20
Testing effectiveness (Phase 2)UnknownNCT02452294
What this trial is testing

Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)

Who this might be right for
Malignant MelanomaMetastases
University Hospital Tuebingen 22
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Load More Results